Key Points - Fengshan Group clarified that its sales do not involve solid-state battery electrolyte materials [1] - Zhiwei Co., Ltd. plans to invest approximately 1.5 billion yuan in the construction of high-end cast steel pump and valve components manufacturing project [1] - Tianyong Intelligent won a bid for a 58.8 million yuan DHE high-efficiency platform production line engine assembly line project [1] - Hanwei Technology intends to sell 65% of its stake in Hanwei Zhiyuan [1] - Huaxin Environmental plans to repurchase shares worth between 40 million to 80 million yuan [1] - Xin Nuo Wei is planning to issue E-shares and list on the Hong Kong Stock Exchange [1] - Shareholders of Run Da Medical, Zhu Wenyi and Liu Hui, plan to reduce their holdings by no more than 2.99% [1] - Feng Assistant intends to raise no more than 984 million yuan through a private placement to actual controllers [1] - Jiaotong Sino's chairman Li Wei has been placed under detention [1] Investment Projects - Nong Shang Environment's subsidiary plans to invest in the construction of intelligent computing center infrastructure [1] - Sai En Si (Fujian Longli Chemical) plans to invest no more than 300 million yuan in the expansion of the selection agent project [1] - Bin Hua Co. intends to invest 1.421 billion yuan in the construction of an integrated source network load storage project [1] Contracts and Acquisitions - Zhong Wu Drone signed a major contract worth 615 million yuan [1] - Xin Nuo Wei plans to acquire a 29% stake in Ju Shi Bio [1] - Huaheng Biological submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [1] - Kete Power plans to issue shares overseas (H-shares) and apply for listing on the Hong Kong Stock Exchange [1]

Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [4] - Bee Assistant plans to raise no more than 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [5] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Three squirrels have received approval from the China Securities Regulatory Commission for H-share issuance, with plans to issue up to 81.5483 million shares [7] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [8] Group 2 - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind, solar, and energy storage [9] - Sains plans to invest no more than 300 million yuan in the expansion of its selection agent project [10] Group 3 - Hunan YN reports no significant changes in its internal and external operating environment [11] - Electric Power Investment has had its major asset replacement review suspended by the Shenzhen Stock Exchange due to expired financial documents [12] - Guanzhong Ecological is in the planning stage for acquiring a 51% stake in Hangzhou Actuary [13][14] Group 4 - Aima Technology's subsidiary is transferring production capacity and ceasing operations due to strategic adjustments [17] - Fosun Pharma's subsidiary has received approval for clinical trials of a new drug [18] - SAIC Group's subsidiary plans to invest 666 million yuan in the restructuring of SAIC Hongyan [19] Group 5 - Hanwei Technology plans to sell 65% of Hanwei Zhiyuan for approximately 440 million yuan [20] - Xingtong Co. has been awarded new capacity for coastal inter-provincial bulk liquid hazardous goods transportation [21][22] Group 6 - EVE Battery Investment received a cash dividend of 375 million HKD from its associate company [23] - Shanmei International's chairman has resigned due to work changes [24] - Weiye Co.'s chairman has resigned for personal reasons [25] Group 7 - Jiao Da Sino's chairman has been placed under detention [26] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [27][28] - *ST Zhengping's stock has been suspended for investigation due to abnormal price fluctuations [29] Group 8 - Zhenray Technology's chairman has had detention measures lifted [30] - Shiming Technology's chairman has had detention measures changed to a warning [31] - Nanxin Pharmaceutical is under investigation by the CSRC for suspected violations in annual report disclosures [32] Group 9 - Daqian Ecology's shareholder plans to reduce holdings by up to 3% [33] - Rundar Medical's shareholders plan to reduce holdings by up to 2.99% [34][35] - Saili Medical's shareholder plans to reduce holdings by up to 2% [36] Group 10 - Huaxin Environmental plans to repurchase shares for 40 to 80 million yuan [37] - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [38] - Zhongwu Drone has signed a significant contract worth 615 million yuan for drone systems [39]

格隆汇9月30日丨大千生态(603955.SH)公布，出于经营发展需要，新华发行集团计划通过集中竞价、大 宗交易方式减持公司股票不超过4,071,600股，减持比例不超过公司总股本的3%，其中，通过集中竞价 交易方式减持不超过1,357,200股（不超过公司总股本的1%），以大宗交易方式减持不超过2,714,400股 （不超过公司总股本的2%）。本次减持计划自本公告披露之日起15个交易日后的3个月内实施。 ...

Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [2] - Bee Assistant plans to raise up to 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [3] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [4] Group 2 - Three squirrels received approval from the China Securities Regulatory Commission for H-share issuance, planning to issue up to 81.5483 million shares [5] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [6] - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind and solar energy [7] Group 3 - Sainz's subsidiary plans to invest up to 300 million yuan in the expansion of selection and extraction agents [8] - Hunan YN reported no significant changes in its internal and external operating environment [9] - Electric Power Investment plans to restructure assets and has received a notice from the Shenzhen Stock Exchange to suspend review [10] Group 4 - Guanzhong Ecology is in the planning stage to acquire 51% of Hangzhou Actuary [11] - Aima Technology announced the transfer and suspension of production capacity at its subsidiary in Guangdong [12] - Fosun Pharma's subsidiary received approval for clinical trials of a new drug [13] Group 5 - EVE Battery Investment received a cash dividend of 375 million HKD from its indirect associate, Simoer International [14] - Shanmei International announced a change in its board leadership due to personnel changes [15] - Weiye Co. announced the resignation of its chairman for personal reasons [16] Group 6 - Jiaoda Sinuo's chairman is under detention, and the company has appointed a new acting chairman [17] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [18] - ST Zhengping's stock price has seen an abnormal increase, leading to a suspension for investigation [19] Group 7 - Daqian Ecology's shareholder plans to reduce its stake by up to 3% [20] - Rundat Medical's shareholders plan to collectively reduce their stake by up to 2.99% [21] - Seli Medical's shareholder plans to reduce its stake by up to 2% [22] Group 8 - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [23] - Zhongwu Drone signed a significant contract worth 615 million yuan for drone systems [24]

大千生态（603955）(603955.SH)发布公告，出于经营发展需要，新华发行集团计划通过集中竞价、大 宗交易方式减持公司股票不超过407.16万股，减持比例不超过公司总股本的3%。 ...

智通财经APP讯，大千生态(603955.SH)发布公告，出于经营发展需要，新华发行集团计划通过集中竞 价、大宗交易方式减持公司股票不超过407.16万股，减持比例不超过公司总股本的3%。 ...

证券代码：603955 证券简称：大千生态 公告编号：2025-065 大千生态环境集团股份有限公司 持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 大股东持股的基本情况 截至本公告披露日，安徽新华发行（集团）控股有限公司（以下简称"新华 发行集团"）持有大千生态环境集团股份有限公司（以下简称"公司"）12,214,800 股无限售条件流通股，占公司总股本的 9.00%。上述股份来源于首次公开发行股 票前取得及发行上市后资本公积金转增的股份。 减持计划的主要内容 出于经营发展需要，新华发行集团计划通过集中竞价、大宗交易方式减持公 司股票不超过 4,071,600 股，减持比例不超过公司总股本的 3%，其中，通过集中 竞价交易方式减持不超过 1,357,200 股（不超过公司总股本的 1%），以大宗交易 方式减持不超过 2,714,400 股（不超过公司总股本的 2%）。本次减持计划自本公 告披露之日起 15 个交易日后的 3 个月内实施。减持价格按照市场价格确定，若 ...

大千生态公告，持股9.00%的股东安徽新华发行（集团）控股有限公司计划自公告披露之日起15个交易 日后的2025年10月30日至2026年1月29日期间，通过集中竞价减持不超过135.72万股及大宗交易减持不 超过271.44万股，合计减持不超过407.16万股，占公司总股本的3%。 ...

证券代码：603955 证券简称：大千生态 公告编号：2025-064 大千生态环境集团股份有限公司 2025年第三次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 本次股东大会由公司董事会召集，董事长张源先生主持，大会采用现场投票 和网络投票相结合的方式进行表决，会议的召开和表决方式符合《公司法》和《公 司章程》的规定，合法有效。 (五) 公司董事、监事和董事会秘书的出席情况 1、 公司在任董事9人，出席9人； 2、 公司在任监事5人，出席5人； (一) 股东大会召开的时间：2025 年 9 月 29 日 (二) 股东大会召开的地点：南京市鼓楼区集庆门大街 270 号苏宁睿城慧谷 E-06 号楼 45 层 4505 室公司会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情 况： | 1、出席会议的股东和代理人人数 | 125 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | ...

大千生态 法律意见书 江苏世纪同仁律师事务所关于 大千生态环境集团股份有限公司 2025 年第三次临时股东大会的法律意见书 致：大千生态环境集团股份有限公司 一、关于本次股东大会的召集、召开程序 1、本次股东大会由董事会召集，2025 年 9 月 12 日，贵公司召开第五届董 事会第十九次会议，决定于 2025 年 9 月 29 日召开 2025 年第三次临时股东大会。 2025 年 9 月 13 日，贵公司在《上海证券报》《中国证券报》《证券时报》《证 券日报》、上海证券交易所网站（www.sse.com.cn）上刊登了《大千生态环境集 团股份有限公司关于召开公司 2025 年第三次临时股东大会的通知》。贵公司在 本次股东大会召开 15 日前刊登了会议通知。 2、贵公司本次股东大会在南京市鼓楼区集庆门大街270号苏宁睿城慧谷E-06 1 大千生态 法律意见书 根据《中华人民共和国公司法》、《中华人民共和国证券法》和中国证监会 《上市公司股东大会规则》等法律、法规和规范性文件以及公司《章程》的规定， 本所受贵公司董事会的委托，指派本所律师出席贵公司 2025 年第三次临时股东 大会，并就本次股东大会的召集、召 ...